Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Comprehensive Look at Vascular Access

This study has been completed.
Information provided by (Responsible Party):
Christie Medical Holdings, Inc. Identifier:
First received: July 9, 2012
Last updated: January 30, 2014
Last verified: January 2014

The objective of this study is to show VeinViewer® Vision is an effective vein visualization device for peripheral vascular access, pre-, during, and post access.

Vascular Access

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: A Comprehensive Look at Vascular Access: Utilizing a Near Infrared Vein Visualization Device For Vascular Access Planning, Attempts, and Post Access

Further study details as provided by Christie Medical Holdings, Inc.:

Primary Outcome Measures:
  • The primary endpoint will be total number of attempts for successful cannulation. [ Time Frame: 1 day ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Amount of time for successful venous access [ Time Frame: 1 day ] [ Designated as safety issue: No ]

Enrollment: 196
Study Start Date: May 2012
Study Completion Date: July 2013
Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Standard IV Access without device
IV access with VeinViewer device


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients at a medical facility requiring IV access.


Inclusion Criteria:

  • Requires peripheral venous access
  • Intact skin on areas of assessment
  • Patient and/or parent or legal guardian is able to understand consent

Exclusion Criteria:

  • No Intact skin
  • Patient is under anesthesia during peripheral venous access
  • Patient is not a suitable candidate, as determined by the discretion of the investigator
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01638065

United States, California
LA County Hospital
Los Angeles, California, United States, 90033
United States, Illinois
Good Samaritan Hospital
Downers Grove, Illinois, United States, 60515
Sponsors and Collaborators
Christie Medical Holdings, Inc.
  More Information

No publications provided

Responsible Party: Christie Medical Holdings, Inc. Identifier: NCT01638065     History of Changes
Other Study ID Numbers: CP1011
Study First Received: July 9, 2012
Last Updated: January 30, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Christie Medical Holdings, Inc.:
vein identification
vascular access processed this record on November 20, 2014